Nonetheless, CD4+CD25+FOXP3+ T cells remains the central focus of Treg-based research in cancer biology due to their potent immunosuppressive functions and their presence in a wide range of tumor types (76, 86). This evidence concerns the gene FOXP3 and cancer.